Your Information is 100% Secure And Will Never Be Shared With Anyone.

Strategenic’s Blueprint for Growth©

The Blueprint for Growth© is based on 20 years of research into companies that consistently outperform their industry.

Our clients start by using our Blueprint for Growth© evaluation to benchmark their company against those impressive organisations. It is an excellent foundation for business strategy because the leadership team can all agree exactly where the company stands and where they need to focus. Then we guide them through our Business Strategy for Growth service to develop an effective strategy and to embed all the characteristics of fast growth companies into the way they work.

Why Strategenic Business Strategy Consultancy?

Why Strategenic Business Strategy Consultancy?
  • Blueprint for Growth© based on 20 years of research into fast growing companies
  • Track record – you are in safe hands
  • Successful clients across the UK, USA and Europe
  • Benchmark your company for the best return on investment
  • Focus on results
  • Long term plans and short term wins
  • Total honesty
  • Attract more of the clients you most want
  • Align your staff – one team, pulling together
  • Attract the best talent

Happy clients say it all - Business Strategy for Growth

  • “When I look back at how hard we have worked, what we have achieved and where we are headed I realise working with you on our Strategy was one of my good decisions.”

    Client confidentialMD, Pan- European Training Company
  • “You generate excitement and interest in the projects you work on. You are particularly effective at getting organisations to take action. It is good to see how you commit 120% and get the job done. While collaborative you have take charge qualities that will not let teams deviate from the goal. Great results. On time. High integrity”

    Qaalfa DibeehiVP, Forrester
  • “Your talent and extensive global experience bring a wealth of expertise in driving customer-centric transformational change”

    Client confidentialSenior Executive, Fortune 500 pharmaceutical company